Organic acids have recently been identified as promising replacements for antibiotics in aquafeeds that promote fish growth and feed efficiency. This study evaluated the inclusion of fumaric acid (FA; 0, 5, 10, 15, 20, and 30 g/kg) in diets (350 g/kg CP; 3.4 kcal digestible energy/g) of Nile tilapia juveniles. Fish (average weight 1.7 ± 0.1 g) were distributed in three 40 L aquaria per treatment (13 fish/aquaria) in a completely randomized design. Over 35 days, the fish received the experimental diets three times daily to apparent satiety. The maximum weight gain, feed efficiency ratio, and protein efficiency ratio were recorded in fish supplemented with 14–15 g/kg FA. After 28 days, Enterobacteriaceae was registered only in the gut of tilapia without FA augmentation. Gram-negative bacteria in the fish gut decreased (p < 0.05) in fish receiving 17 g/kg of dietary FA, increased after this level. The intestinal villi height and width were affected (p < 0.05) by FA levels and feeding time. Thus, inclusion of 15 g/kg of FA was effective in promoting growth, improving intestinal morphometry, and decreasing negative gut bacteria of Nile tilapia juveniles after 35 days.
The expansion of aquaculture into new regions and environments to meet the growing demand for food increases the risk of new pathogens that can affect the production of crustaceans (Thitamadee et al., 2016). Indeed, pathogenic agents are a considerable concern in shrimp farms, as the animals are highly susceptible to disease and high mortality rates can occur in these systems (Vadstein et al., 2013).Outbreaks of diseases, particularly white spot syndrome virus (WSSV), continue to be one of the main obstacles facing the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.